Avalyn Pharma Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 25.71 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.14B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis; and AP03, a fixed-dose combination of inhaled pirfenidone and nintedanib to deliver dual antifibrotic mechanisms. Avalyn Pharma Inc. was formerly known as Genoa Pharmaceuticals, Inc. and changed its name to Avalyn Pharma Inc. in July 2017. The company was incorporated in 2011 and is based in Boston, Massachusetts.
Details
| Name | Avalyn Pharma Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 55 |
| Founded | 2011 |
| Ipo Date | 2026-04-30 |
| Ceo | Lyn Baranowski |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 18.00 |
| Isin | US05348Y1055 |
| Cusip | 05348Y105 |
| Cik | 1540171 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Lyn Baranowski | Chief Executive Officer, President and Director |
| Douglas R. Carlson | Chief Financial Officer and Chief Business Officer |
| Dr. Melissa Rhodes DABT, Ph.D. | Chief Operating Officer |
| Dr. Howard M. Lazarus M.D. | Chief Medical Officer |
| Cassie Saitow | Senior Director of IR and Corporate Communications |
| Adam H, Golden J.D. | General Counsel and Head of Business Development |
| Dr. Craig Conoscenti M.D. | Senior Vice President of Clinical Development |
| James Bishop | Senior Vice President of Business Operations |
| Dr. Stephen Pham Ph.D. | Senior Vice President of Product Development |
| Jill Denning | Senior Vice President of Clinical Development Operations |
Contact
| Address | 105 W First Street, Boston, Massachusetts 02127, United States |
| Phone | (206) 707-0340 |
| Website | https://www.avalynpharma.com |